Understand Every Side.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Social Media
Artificial Intelligence
Natural Disasters
Donald Trump
Republican Party
Soccer
Property
Senate
YouTube
US Politics
Published • loading... • Updated

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Summary by psychiatrictimes.com
Recent research reveals dopamine partial agonists significantly reduce somnolence in major depressive disorder and schizophrenia compared with D2 receptor antagonists.

1 Articles

All
Left
Center
Right
psychiatrictimes.compsychiatrictimes.com

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Recent research reveals dopamine partial agonists significantly reduce somnolence in major depressive disorder and schizophrenia compared with D2 receptor antagonists.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

psychiatrictimes.com broke the news in on Thursday, May 29, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal